Effects of COVID-19 on Respiratory System

被引:0
|
作者
Karahalil, Bensu [1 ]
Deniz, Muhammed Ercan [1 ]
Iyigundogdu, Irem [1 ]
Tumer, Miray [1 ]
机构
[1] Gazi Univ, Fac Pharm, Dept Pharmaceut Toxicol, Ankara, Turkey
来源
GAZI MEDICAL JOURNAL | 2020年 / 31卷 / 3A期
关键词
COVID-19; viral entry; ACE2; receptor; respiratory system; SARS-CoV; ARDS; CORONAVIRUS;
D O I
10.12996/gmj.2020.124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronavirus disease 2019 (COVID-19) was caused by a novel type of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was originated in Wuhan, China in December 2019. It spreads rapidly all over the world since respiratory virus infection can occur through many easy ways (e.g. contact, droplet spray, aerosol) and besides, asymptomatic people also have contagiousness. So far, there have been 23,491,520 confirmed cases of COVID-19, including 809,970 deaths, reported to World Health Organization (WHO), which declared it as a significant threat to global health. Fever, fatigue, and dry cough are the commonly observed symptoms in the patients. In COVID-19, the main affected system is respiratory system and some cases demonstrate a rapid progression to acute respiratory distress syndrome (ARDS), while other organs are less involved. Angiotensin-converting enzyme 2 receptor-virus association is essential and responsible for the development of the disease. SARS-CoV-2 causes deaths through its severe effects on the respiratory system.
引用
收藏
页码:528 / 531
页数:4
相关论文
共 50 条
  • [21] COVID-19 and renin angiotensin aldosterone system: Pathogenesis and therapy
    Babajani, Fatemeh
    Kakavand, Atefeh
    Mohammadi, Hossien
    Sharifi, Armin
    Zakeri, Saba
    Asadi, Soheila
    Afshar, Zeinab Mohseni
    Rahimi, Zohreh
    Sayad, Babak
    HEALTH SCIENCE REPORTS, 2021, 4 (04)
  • [22] Renin-angiotensin system at the heart of COVID-19 pandemic
    Alifano, Marco
    Alifano, Pietro
    Forgez, Patricia
    Iannelli, Antonio
    BIOCHIMIE, 2020, 174 : 30 - 33
  • [23] Association between COVID-19 and cardiovascular disease
    Srivastava, Kamna
    IJC HEART & VASCULATURE, 2020, 29
  • [24] The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19
    Braga, Cassia L.
    Silva-Aguiar, Rodrigo P.
    Battaglini, Denise
    Peruchetti, Diogo B.
    Robba, Chiara
    Pelosi, Paolo
    Rocco, Patricia R. M.
    Caruso-Neves, Celso
    Silva, Pedro L.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2020, 8 (04):
  • [25] The effects of COVID-19 on the vestibular system
    Zaubitzer, Lena
    Ludwig, Sonja
    Berkemann, Michelle
    Walter, Beatrice
    Jungbauer, Frederic
    Held, Valentin
    Hegemann, Stefan C. A.
    Rotter, Nicole
    Schell, Angela
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [26] Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19
    Badraoui, Riadh
    Alrashedi, Mousa M.
    El-May, Michele Veronique
    Bardakci, Fevzi
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (17): : 6842 - 6851
  • [27] COVID-19 and the endocrine system: exploring the unexplored
    Pal, R.
    Banerjee, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (07) : 1027 - 1031
  • [28] The renin angiotensin aldosterone system and COVID-19
    Alsufyani, Hadeel A.
    Docherty, James R.
    SAUDI PHARMACEUTICAL JOURNAL, 2020, 28 (08) : 977 - 984
  • [29] Cardiovascular system and COVID-19: manifestations and therapeutics
    Mahenthiran, Ajay K.
    Mahenthiran, Ashorne K.
    Mahenthiran, Jo
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2020, 21 (03) : 399 - 409
  • [30] Nicotine and the nicotinic cholinergic system in COVID-19
    Tizabi, Yousef
    Getachew, Bruk
    Copeland, Robert L.
    Aschner, Michael
    FEBS JOURNAL, 2020, 287 (17) : 3656 - 3663